4-[3-[4-[2-[4-[2-[5-chloro-1-(6-methylidene-2-oxopiperidin-3-yl)-6-oxopyridazin-4-yl]oxyethyl]piperazin-1-yl]ethoxy]phenyl]-4,4-dimethyl-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile

C37H38ClF3N8O5S — CID 135273199

IUPAC4-[3-[4-[2-[4-[2-[5-chloro-1-(6-methylidene-2-oxopiperidin-3-yl)-6-oxopyridazin-4-yl]oxyethyl]piperazin-1-yl]ethoxy]phenyl]-4,4-dimethyl-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile
SMILESC=C1CCC(n2ncc(OCCN3CCN(CCOc4ccc(N5C(=S)N(c6ccc(C#N)c(C(F)(F)F)c6)C(=O)C5(C)C)cc4)CC3)c(Cl)c2=O)C(=O)N1
InChIInChI=1S/C37H38ClF3N8O5S/c1-23-4-11-29(32(50)44-23)49-33(51)31(38)30(22-43-49)54-19-17-46-14-12-45(13-15-46)16-18-53-27-9-7-25(8-10-27)48-35(55)47(34(52)36(48,2)3)26-6-5-24(21-42)28(20-26)37(39,40)41/h5-10,20,22,29H,1,4,11-19H2,2-3H3,(H,44,50)
InChIKeyMEZBYJOOLMCQNC-UHFFFAOYSA-N
MW799.28 g/mol
LogP4.74
Rot. Bonds11

About 4-[3-[4-[2-[4-[2-[5-chloro-1-(6-methylidene-2-oxopiperidin-3-yl)-6-oxopyridazin-4-yl]oxyethyl]piperazin-1-yl]ethoxy]phenyl]-4,4-dimethyl-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile

4-[3-[4-[2-[4-[2-[5-chloro-1-(6-methylidene-2-oxopiperidin-3-yl)-6-oxopyridazin-4-yl]oxyethyl]piperazin-1-yl]ethoxy]phenyl]-4,4-dimethyl-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile (PubChem CID 135273199) has the molecular formula C37H38ClF3N8O5S and a molecular weight of 799.28 g/mol. Its IUPAC name is 4-[3-[4-[2-[4-[2-[5-chloro-1-(6-methylidene-2-oxopiperidin-3-yl)-6-oxopyridazin-4-yl]oxyethyl]piperazin-1-yl]ethoxy]phenyl]-4,4-dimethyl-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile.

Molecular Properties

Compound Name4-[3-[4-[2-[4-[2-[5-chloro-1-(6-methylidene-2-oxopiperidin-3-yl)-6-oxopyridazin-4-yl]oxyethyl]piperazin-1-yl]ethoxy]phenyl]-4,4-dimethyl-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile
PubChem CID135273199
Molecular FormulaC37H38ClF3N8O5S
Molecular Weight799.28 g/mol
Exact Mass798.23
IUPAC Name4-[3-[4-[2-[4-[2-[5-chloro-1-(6-methylidene-2-oxopiperidin-3-yl)-6-oxopyridazin-4-yl]oxyethyl]piperazin-1-yl]ethoxy]phenyl]-4,4-dimethyl-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile
SMILESC=C1CCC(n2ncc(OCCN3CCN(CCOc4ccc(N5C(=S)N(c6ccc(C#N)c(C(F)(F)F)c6)C(=O)C5(C)C)cc4)CC3)c(Cl)c2=O)C(=O)N1
InChIInChI=1S/C37H38ClF3N8O5S/c1-23-4-11-29(32(50)44-23)49-33(51)31(38)30(22-43-49)54-19-17-46-14-12-45(13-15-46)16-18-53-27-9-7-25(8-10-27)48-35(55)47(34(52)36(48,2)3)26-6-5-24(21-42)28(20-26)37(39,40)41/h5-10,20,22,29H,1,4,11-19H2,2-3H3,(H,44,50)
InChIKeyMEZBYJOOLMCQNC-UHFFFAOYSA-N
XLogP4.74
TPSA136.27 Ų
H-Bond Donors1
H-Bond Acceptors11
Rotatable Bonds11
Heavy Atoms55
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500799.28
LogP ≤ 54.74
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'}

Analyze 4-[3-[4-[2-[4-[2-[5-chloro-1-(6-methylidene-2-oxopiperidin-3-yl)-6-oxopyridazin-4-yl]oxyethyl]piperazin-1-yl]ethoxy]phenyl]-4,4-dimethyl-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[3-[4-[2-[4-[2-[5-chloro-1-(6-methylidene-2-oxopiperidin-3-yl)-6-oxopyridazin-4-yl]oxyethyl]piperazin-1-yl]ethoxy]phenyl]-4,4-dimethyl-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile?
The IUPAC name of 4-[3-[4-[2-[4-[2-[5-chloro-1-(6-methylidene-2-oxopiperidin-3-yl)-6-oxopyridazin-4-yl]oxyethyl]piperazin-1-yl]ethoxy]phenyl]-4,4-dimethyl-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile (CID 135273199) is 4-[3-[4-[2-[4-[2-[5-chloro-1-(6-methylidene-2-oxopiperidin-3-yl)-6-oxopyridazin-4-yl]oxyethyl]piperazin-1-yl]ethoxy]phenyl]-4,4-dimethyl-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile.
What is the SMILES notation for 4-[3-[4-[2-[4-[2-[5-chloro-1-(6-methylidene-2-oxopiperidin-3-yl)-6-oxopyridazin-4-yl]oxyethyl]piperazin-1-yl]ethoxy]phenyl]-4,4-dimethyl-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile?
The canonical SMILES for 4-[3-[4-[2-[4-[2-[5-chloro-1-(6-methylidene-2-oxopiperidin-3-yl)-6-oxopyridazin-4-yl]oxyethyl]piperazin-1-yl]ethoxy]phenyl]-4,4-dimethyl-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile is C=C1CCC(n2ncc(OCCN3CCN(CCOc4ccc(N5C(=S)N(c6ccc(C#N)c(C(F)(F)F)c6)C(=O)C5(C)C)cc4)CC3)c(Cl)c2=O)C(=O)N1.
What is the InChIKey of 4-[3-[4-[2-[4-[2-[5-chloro-1-(6-methylidene-2-oxopiperidin-3-yl)-6-oxopyridazin-4-yl]oxyethyl]piperazin-1-yl]ethoxy]phenyl]-4,4-dimethyl-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile?
The InChIKey is MEZBYJOOLMCQNC-UHFFFAOYSA-N. The full InChI is InChI=1S/C37H38ClF3N8O5S/c1-23-4-11-29(32(50)44-23)49-33(51)31(38)30(22-43-49)54-19-17-46-14-12-45(13-15-46)16-18-53-27-9-7-25(8-10-27)48-35(55)47(34(52)36(48,2)3)26-6-5-24(21-42)28(20-26)37(39,40)41/h5-10,20,22,29H,1,4,11-19H2,2-3H3,(H,44,50).
What are the key properties of 4-[3-[4-[2-[4-[2-[5-chloro-1-(6-methylidene-2-oxopiperidin-3-yl)-6-oxopyridazin-4-yl]oxyethyl]piperazin-1-yl]ethoxy]phenyl]-4,4-dimethyl-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile?
4-[3-[4-[2-[4-[2-[5-chloro-1-(6-methylidene-2-oxopiperidin-3-yl)-6-oxopyridazin-4-yl]oxyethyl]piperazin-1-yl]ethoxy]phenyl]-4,4-dimethyl-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile has a molecular weight of 799.28 g/mol, XLogP of 4.74, 11 rotatable bonds, 1 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[3-[4-[2-[4-[2-[5-chloro-1-(6-methylidene-2-oxopiperidin-3-yl)-6-oxopyridazin-4-yl]oxyethyl]piperazin-1-yl]ethoxy]phenyl]-4,4-dimethyl-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile is sourced from PubChem (CID 135273199), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).